Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Pavlo Gilchuk(AstraZeneca (Japan)), James E. Crowe(Vanderbilt University Medical Center), Bronwyn M. Gunn(Washington State University), Robert H. Carnahan(Vanderbilt University Medical Center), Alexander Bukreyev(Galveston College), Natalia A. Kuzmina(Galveston College), Kai Huang(Galveston College), Philipp A. Ilinykh(Houston Methodist), Robert W. Cross(The University of Texas Medical Branch at Galveston), George K. Lewis(University of Maryland, Baltimore), Benjamin Ohiaeri(First Consultants Medical Center), Rachel S. Nargi(Vanderbilt University Medical Center), Hannah L. Turner(Scripps Research Institute), Tanwee Alkutkar(Scripps Research Institute), Chad E. Mire(United States Department of Agriculture), Adaora Okoli(First Consultants Medical Center), Robin Bombardi(Vanderbilt University Medical Center), Edgar Davidson(Integral Molecular (United States)), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Thomas W. Geisbert(The University of Texas Medical Branch at Galveston), Aubrey L. Bryan(Integral Molecular (United States)), Chiara Orlandi(University of Maryland, Baltimore), Benjamin J. Doranz(Integral Molecular (United States)), Charles D. Murin(Scripps Research Institute), Andrew B. Ward(Scripps Research Institute), Erica Ollmann Saphire(La Jolla Institute for Immunology), Morris Ibeawuchi(First Consultants Medical Center), Robin Flinko(University of Maryland, Baltimore), Pilar X. Altman(Scripps Research Institute), Jacob C. Milligan(Scripps Research Institute), Sean Hui(Scripps Research Institute), Sheng Li(University of California San Diego), Megan E. Vodzak(Vanderbilt University Medical Center)
Cited by 97
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k